EMD Millipore, Charles River sign licensing contract
The companies will collaborate to integrate the technology into viral clearance services provided by Charles River, which is designed to result in a consistent study outcome for clients.
Isomorphic Labs has raised $5bn in a Series C financing round to support the development of its AI platform and advance its therapeutic candidates towards clinical evaluation.
The European Medicines Agency’s (EMA) acceptance of the marketing authorization application (MAA) of peginesatide has triggered the milestone. Peginesatide, indicated to treat anemia associated with chronic kidney disease